StonvexLoading…
StonvexStonvexStonvexCore line items from BABB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-11-30 | Annual 2024 2024-12-31 | Annual 2024 2024-11-30 | Annual 2023 2023-12-31 |
|---|---|---|---|---|
Revenue | $3.44M | $3.55M | $3.55M | $3.51M |
Operating Income | $721.63K | $665.29K | $665.29K | $614.77K |
Net Income | $559.04K | $525.20K | $525.20K | $467.32K |
EPS (Diluted) | $0.08 | $0.07 | $0.07 | $0.06 |
Total Assets | $4.78M | Not available | $4.84M | Not available |
Total Liabilities | $1.32M | Not available | $1.50M | Not available |
Cash & Equivalents | $2.15M | Not available | $2.18M | Not available |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 7.26M | 7.26M | 7.26M | 7.26M |